JPMorgan Chase & Co. Has $66.90 Million Stock Position in Sabra Healthcare REIT, Inc. $SBRA

JPMorgan Chase & Co. boosted its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 33.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,589,253 shares of the real estate investment trust’s stock after purchasing an additional 903,841 shares during the period. JPMorgan Chase & Co. owned about 1.44% of Sabra Healthcare REIT worth $66,904,000 at the end of the most recent quarter.

A number of other large investors have also recently modified their holdings of the business. Founders Capital Management bought a new position in shares of Sabra Healthcare REIT in the 3rd quarter valued at $28,000. Danske Bank A S bought a new stake in shares of Sabra Healthcare REIT during the 3rd quarter worth $30,000. Larson Financial Group LLC boosted its stake in Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after buying an additional 553 shares in the last quarter. Covestor Ltd boosted its stake in Sabra Healthcare REIT by 23,720.0% in the third quarter. Covestor Ltd now owns 2,382 shares of the real estate investment trust’s stock valued at $45,000 after buying an additional 2,372 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in Sabra Healthcare REIT by 150.7% in the second quarter. EverSource Wealth Advisors LLC now owns 2,555 shares of the real estate investment trust’s stock valued at $47,000 after acquiring an additional 1,536 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on SBRA. Truist Financial boosted their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “hold” rating in a research note on Friday, March 13th. Citigroup raised their price target on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, February 18th. Citizens Jmp lifted their price target on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a report on Wednesday, February 18th. Wall Street Zen cut shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $22.00 price objective on shares of Sabra Healthcare REIT in a research note on Monday, December 15th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $21.90.

Sabra Healthcare REIT Trading Down 1.9%

Shares of SBRA stock opened at $20.24 on Friday. Sabra Healthcare REIT, Inc. has a twelve month low of $15.75 and a twelve month high of $21.07. The stock’s fifty day simple moving average is $19.74 and its 200 day simple moving average is $19.05. The company has a quick ratio of 4.29, a current ratio of 4.29 and a debt-to-equity ratio of 0.90. The firm has a market capitalization of $5.10 billion, a P/E ratio of 31.63, a P/E/G ratio of 1.64 and a beta of 0.64.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its quarterly earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). Sabra Healthcare REIT had a net margin of 20.09% and a return on equity of 5.63%. The firm had revenue of $201.35 million for the quarter, compared to analyst estimates of $201.97 million. During the same period in the previous year, the business posted $0.36 earnings per share. The business’s revenue for the quarter was up 16.2% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, sell-side analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, February 27th. Shareholders of record on Friday, February 13th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 5.9%. The ex-dividend date of this dividend was Friday, February 13th. Sabra Healthcare REIT’s payout ratio is presently 187.50%.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.